A novel inhibitor of human cytomegalovirus acts through a specific antiviral mechanism that involves the helicase-primase complex.

Cytovene (ganciclovir) - Roche

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/42439813

Alyza Skaist; Arun Kapoor; Ayan K Ghosh; Michael Forman; Ravit Arav-Boger; Sarah Wheelan

Jul 14, 2026